|
Characteristic
|
β-coefficient
|
STAT
|
P Value
|
|---|
|
BMI, kg/m2
|
−0.569
|
−1.506
|
0.133
|
|
SBP, mmHg
|
−3.082
|
−1.117
|
0.265
|
|
DBP, mmHg
|
−2.583
|
−1.196
|
0.233
|
|
WC, cm
|
−0.440
|
−0.373
|
0.709
|
|
HP, cm
|
−1.148
|
−1.196
|
0.233
|
|
TP,g/L
|
0.116
|
0.185
|
0.853
|
|
Albumin,g/L
|
0.060
|
0.106
|
0.915
|
|
Globulin,g/L
|
−0.424
|
−0.558
|
0.577
|
|
A/G
|
0.039
|
0.897
|
0.370
|
|
TBIL, umol/L
|
1.220
|
1.511
|
0.132
|
|
DBIL, umol/L
|
0.703
|
1.542
|
0.124
|
|
TBA,umol/L
|
0.154
|
0.156
|
0.876
|
|
ALT, U/L
|
7.632
|
2.013
|
0.045
|
|
AST, U/L
|
2.446
|
0.857
|
0.393
|
|
FBG, mmol/L
|
0.025
|
0.130
|
0.897
|
|
LDL-C, mmol/L
|
−0.101
|
−0.903
|
0.367
|
|
TG, mmol/L
|
−0.437
|
−1.968
|
0.050
|
|
TC, mmol/L
|
−0.019
|
−0.135
|
0.893
|
|
HDL-C, mmol/L
|
−0.003
|
−0.080
|
0.936
|
- Abbreviations: BMI Body Mass Index, SBP systemic blood pressure, DBP diastolic blood pressure, WC Waist circumference, HP Hip circumference, TP Total Protein, A/G the ratio of albumin to globulin, TBIL total bilirubin, DBIL direct bilirubin, TBA total bile acid, ALT glutamic-pyruvic transaminase, AST glutamic oxalacetic transaminase, FBG fasting blood-glucose, LDL-C low density lipoprotein cholesterin, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, NAFLD nonalcoholic fatty liver disease
- aβ-coefficient: estimated quantitative effect of rs28365927 A Carriers on a phenotype of NAFLD, STAT: T statistic, P: level of statistical significance of the covariate(age and gender) adjusted linear regression analysis. P-value<0.05 considered as statistically significant (in bold)
